Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Seer Community
NasdaqGS:SEER Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Community Investing Ideas
Seer
Popular
Undervalued
Overvalued
Seer
AN
AnalystConsensusTarget
Consensus Narrative from Analysts
Proteograph Product Suite And Thermo Fisher Partnership Will Open Markets
Key Takeaways Strategic investments in commercial infrastructure and leadership aim to support revenue growth through increased productivity and sales effectiveness. Expanding partnerships and product innovation target enhanced adoption and customer value, potentially boosting sales and overall gross margins.
View narrative
US$3.29
FV
37.7% undervalued
intrinsic discount
32.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 months ago
author updated this narrative
Your Valuation for
SEER
SEER
Seer
Your Fair Value
US$
Current Price
US$2.05
52.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-94m
60m
2015
2018
2021
2024
2025
2027
2030
Revenue US$59.9m
Earnings US$7.6m
Advanced
Set Fair Value